Association of Epstein-Barr virus and nasopharyngeal carcinoma in caucasian patients

Annals of Otology, Rhinology and Laryngology

Volumn 111, Issue 3, 2002, Pages 210-216

  Plaza, Guillermo ^a,c   Santón, Almudena ^a   Manzanal, Ana I ^a   Martínez Montero, Juan Carlos ^b   Fogué, Luis ^a   Bellas, Carmen ^a  

^a Program of Molecular Pathology   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

Epstein Barr virus; In situ hybridization; Latent membrane protein 1; Nasopharyngeal carcinoma; ZEBRA protein

Indexed keywords

IMMEDIATE EARLY PROTEIN BZLF1; LATENT MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; LYSIS; MALE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SPAIN;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS INFECTIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RIBOSOMAL PROTEINS; RNA, VIRAL; RNA-BINDING PROTEINS; SPAIN; SURVIVAL ANALYSIS; TRANS-ACTIVATORS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

EID: 0036121533     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940211100304     Document Type: Article

References (42)

1. Epstein-Barr virus in tumours
2. Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus
3. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization
4. EpsteinBarr virus and the B cell: That’s all it takes
5. Differences in the growth pattern and clinical course of EBV-LMP1 expressing and nonexpressing nasopharyngeal carcinomas
6. Rapid detection of Epstein-Barr viral DNA by nonisotopic in situ hybridization: Correlation with the polymerase chain reaction
7. Comparative analysis of Epstein-Barr virus (EBV) detection by nested-PCR and non-isotopic in situ hybridization in nasopharyngeal carcinoma
8. Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma
9. Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder
10. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia
11. Epstein-Barr virus and carcinomas: Undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus
12. Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction
13. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma
14. Detection of Epstein-Barr virus small RNAs in routine paraffin sections using nonisotopic RNA/RNA in situ hybridization
15. Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization: A correlation with WHO histologic subtypes
16. Expression of bcl-2 and p53 proteins in nasopharyngeal carcinoma. Absence of correlation with the presence of EBV encoded EBER1-2 transcripts and latent membrane protein-1
17. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma: A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens
18. Determination of nonendemic nasopharyngeal carcinoma by in situ hybridization for Epstein-Barr virus EBER1 RNA sensitivity and specificity in cervical node metastasis
19. Epstein-Barr virus and its interaction with the host
20. Bcl-2 Protooncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma
21. Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients
22. Immunohistochemical demonstration of different latent membrane protein-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases
23. Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin’s disease
24. EpsteinBarr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1, and LMP2 transcripts
25. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells
26. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies
27. The Epstein-Barr virus and nasopharyngeal carcinoma
28. Histopathology of nasopharyngeal carcinoma: Correlations with epidemiology, survival rates and other biological characteristics
29. Pathology of nasopharyngeal carcinoma. Proposal of a new histologic classification correlated with prognosis
30. An epidemiologic and clinical study of nasopharyngeal carcinoma
31. Nasopharyngeal carcinoma, histopathological types, association with Epstein-Barr virus
32. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas
33. Expression of the Epstein-Barr latent membrane protein in nasopharyngeal carcinoma biopsy specimens
34. Expression of Ki67 antigen, epidermal growth factor receptor, Epstein-Barr virus-encoded latent membrane protein (LMP1) in nasopharyngeal carcinoma
35. Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells
36. Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus-associated nasopharyngeal carcinoma
37. Clonal proliferations of cells infected with EpsteinBarr virus in preinvasive lesions related to nasopharyngeal carcinoma
38. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: Implications for vaccine development
39. Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma
40. Epstein-Barr virus and nasopharyngeal cancer
41. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma
42. EBER1 in situ hybridization as an adjuvant for diagnosis of recurrent nasopharyngeal carcinoma